文献速递运动医学关节外科

半月板修复中组织粘合剂应用现状:尚未成熟——系统综述

Current Concepts on Tissue Adhesive Use for Meniscal Repair-We Are Not There Yet: A Systematic Review of the Literature.
PubMed 文献 · Am J Sports Med · 2021-04-15

该系统综述检索PubMed、Embase和Cochrane Library数据库,纳入10项研究共352例半月板修复,其中94例(27%)单纯使用组织粘合剂,258例(73%)联合缝合与粘合剂。所有研究均使用纤维蛋白基粘合剂,9项为证据等级4的病例系列,8项样本量≤40例。半月板愈合率在9项研究中评估,修复失败39例(11%)。结论认为组织粘合剂用于半月板修复显示良好结果,但缺乏高质量对照证据支持常规使用。

要点

  • 所有纳入研究均使用纤维蛋白基组织粘合剂进行半月板修复。
  • 352例修复中27%为单纯粘合剂修复,73%为缝合联合粘合剂修复。
  • 修复失败率为11%(39例),但证据等级低且样本量小。

核心结论

  • 纤维蛋白基组织粘合剂用于半月板修复作为增强或主要修复方式显示良好结果。
  • 缺乏高质量对照证据支持常规使用组织粘合剂进行半月板修复。
  • 目前缺乏专为半月板修复设计的理想组织粘合剂。

研究设计与样本

  • 系统综述,证据等级4。
  • 检索PubMed、Embase和Cochrane Library数据库,纳入2020年1月前发表的英文临床研究。
  • 共纳入10项研究,包含352例半月板修复。

主要发现

  • 94例(27%)为单纯组织粘合剂修复,258例(73%)为缝合联合组织粘合剂修复。
  • 224例修复(64%)同期行前交叉韧带重建。
  • 9项研究为证据等级4的病例系列,8项研究报告的半月板修复队列≤40例。
  • 9项研究评估了半月板愈合率,修复失败见于39例修复(11%)。

临床怎么用

  • 当前证据不支持将组织粘合剂作为半月板修复的常规独立手段。
  • 纤维蛋白基粘合剂可作为缝合修复的辅助增强方式考虑。

局限性

  • 纳入研究多为低证据等级(4级)病例系列,样本量小。
  • 缺乏比较性高质量证据。
  • 所有研究均使用纤维蛋白基粘合剂,缺乏其他类型粘合剂的数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tissue adhesives (TAs) represent a promising alternative or augmentation method to conventional tissue repair techniques. In sports medicine, TA use has been suggested and implemented in the treatment of meniscal tears. The aim of this review was to present and discuss the current evidence and base of knowledge regarding the clinical usage of TAs for meniscal repair. STUDY DESIGN: Systematic review; Level of evidence, 4. METHODS: A systematic literature search was performed using the PubMed, Embase, and Cochrane Library databases for studies reporting on clinical outcomes of TA usage for meniscal repair in humans in the English language published before January 2020. RESULTS: Ten studies were eligible for review and included 352 meniscal repairs: 94 (27%) were TA-based repairs and 258 (73%) were combined suture and TA repairs. Concomitant anterior cruciate ligament reconstruction was performed in 224 repairs (64%). All included studies utilized fibrin-based TA. Of the 10 studies, 9 were evidence level 4 (case series), and 8 reported on a cohort of ≤40 meniscal repairs. Rates of meniscal healing were evaluated in 9 of 10 studies, with repair failure seen in 39 repairs (11%). CONCLUSION: The use of TAs, specifically fibrin-based TAs, for meniscal repair shows good results as either an augmentation or primary repair of various configurations of meniscal tears. However, this review reveals an absence of comparative high-quality evidence supporting the routine use of TAs for meniscal repair and emphasizes the lack of an ideal TA designed for that purpose. Further high-quality research, basic science and clinical, will facilitate the development of new materials and enable testing their suitability for use in meniscal repair.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Marom N, Ode G, Coxe F, et al. Current Concepts on Tissue Adhesive Use for Meniscal Repair-We Are Not There Yet: A Systematic Review of the Literature. Am J Sports Med. 2021. PMID: 33856859. doi:10.1177/03635465211003613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。